Redox Biomarkers in Cancer
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 59
Special Issue Editor
Interests: hematopoietic stem cell; STAT5 signaling; redox signaling; cancer biology; leukemogenesis
Special Issue Information
Dear Colleagues,
Please consider submitting your original research or review article to this Special Issue. There are high quantities of molecular genetic data being generated on cancers of all tissue types. Databases such as The Cancer Genome Atlas (TCGA) house a wealth of potential biomarker information that needs to be extracted. There are also many more specialized databases with this information as well as newly generated investigator-initiated data sets. This Special Issue does not focus directly on the mechanisms of cancer biology but rather on biomarkers related to redox processes that are strongly associated with outcomes in human cancers. Redox control of signaling and phosphorylation is a critical process in cancer. Biomarker linkages to disease sub-types, mutations, and overall or disease-free survival can be novel and lead to subsequent therapeutic advances or valuable prognostic markers for risk stratification. Biomarkers can be mRNAs, metabolites, proteins, etc., and a series of related and inter-connected pathways or gene sets is typically indicative of significant cellular programs. We welcome rigorous studies with strong statistical support based on human patient sample data collected from biorepositories and online resources. If you have identified a potential new redox-related biomarker, this Special Issue is a great place to publish your findings.
Prof. Dr. Kevin D. Bunting
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematopoiesis
- leukemogenesis
- redox signaling
- JAK-STAT pathway
- cancer biology
- stem cell biology
